CN111956772A - Industrial hemp leaf gel for easing pain - Google Patents

Industrial hemp leaf gel for easing pain Download PDF

Info

Publication number
CN111956772A
CN111956772A CN202010810989.8A CN202010810989A CN111956772A CN 111956772 A CN111956772 A CN 111956772A CN 202010810989 A CN202010810989 A CN 202010810989A CN 111956772 A CN111956772 A CN 111956772A
Authority
CN
China
Prior art keywords
extract
rhizoma
radix
percent
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010810989.8A
Other languages
Chinese (zh)
Inventor
苏毅生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujian Fuwei Biotechnology Co ltd
Original Assignee
Fujian Fuwei Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujian Fuwei Biotechnology Co ltd filed Critical Fujian Fuwei Biotechnology Co ltd
Priority to CN202010810989.8A priority Critical patent/CN111956772A/en
Publication of CN111956772A publication Critical patent/CN111956772A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237—Notopterygium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an analgesic and soothing industrial hemp leaf gel, which comprises the following specific components in parts by weight based on 100 parts by weight: 30-70% of water, 10-60% of ethanol, 0.01-2% of centella asiatica extract, 0.01-2% of caulis spatholobi extract and 0.01-2% of radix angelicae pubescentis extract, cannabidiol CBD disclosed by the invention is compatible and synergistic with 6-17 of centella asiatica extract, caulis spatholobi extract, rhizoma dioscoreae extract, rhizoma gastrodiae extract, rhizoma zingiberis recens extract, radix angelicae pubescentis extract, semen cuscutae extract, rhizoma ligustici wallichii extract, rhizoma atractylodis macrocephalae extract, safflower carthamus extract, radix polygalae extract, radix aucklandiae extract, myrrh extract, frankincense extract, angelica sinensis extract, radix sileris extract, notopterygium root extract and other plant extracts, the sensory effect of use is improved by adding vanillylamino.

Description

Industrial hemp leaf gel for easing pain
Technical Field
The invention relates to the technical field of skin care products, in particular to an industrial hemp leaf gel for easing pain and relieving.
Background
Under certain conditions, colloidal particles or macromolecules in a sol or solution are connected with each other to form a spatial network structure, and the structural voids are filled with a liquid (in a xerogel, a gas can be used, and the xerogel is also called an aerogel) serving as a dispersion medium, so that a special dispersion system is called a gel. It has no fluidity. The interior often contains a large amount of liquid. For example, the water content of blood gel and agar can reach more than 99%. It can be divided into elastic gels and brittle gels. The elastic gel loses its dispersion medium and then shrinks significantly in volume, and when the dispersion medium is resorbed, the volume expands again, such as gelatin and the like. Brittle gels do not change shape or volume when they lose or reabsorb the dispersion medium, e.g., silica gels and the like. The process of forming a gel from a solution or sol is called gelation.
The gel has good effect on the skin of a human body, the hydrophilic gel is used as a mask matrix, the interior of the mask matrix is rich in a large amount of nutrients and moisture required by the skin, the mask matrix has strong application performance and no stimulation to the skin, but the existing gel skin care products have no effects of relieving pain and aching pain and promoting blood circulation to remove blood stasis, so that the problem is solved by the industrial hemp leaf gel with the functions of relieving pain and relieving pain.
Disclosure of Invention
Based on the technical problems in the background art, the cannabis related to the invention is industrial cannabis, and the invention provides an industrial cannabis leaf gel for relieving pain.
The invention provides an analgesic and soothing industrial hemp leaf gel, which comprises the following specific components in parts by weight based on 100 parts by weight:
30 to 70 percent of water
10 to 60 percent of ethanol
Centella asiatica extract 0.01-2%
0.01-2% of caulis Spatholobi extract
0.01-2% of Hylocereus undatus extract
Rhizoma Gastrodiae extract 0.01-2%
Ginger extract 0.01-2%
Radix Angelicae Pubescentis extract 0.01-2%
Semen Cuscutae extract 0.01-2%
Rhizoma Ligustici Chuanxiong extract 0.01-2%
0.01-2% of white atractylodes rhizome extract
Carthami flos extract 0.01-2%
0.01-2% of polygala root extract
Radix aucklandiae extract 0.01-2%
0.01-2% of myrrh extract
Olibanum extract 0.01-2%
0.01-2% of angelica extract
0.01-2% of radix Saposhnikoviae extract
Notopterygii rhizoma extract 0.01-2%
0.1 to 3 percent of vanillyl butyl ether
Folium Cannabis extract 0.05-5%
Carbomer 0.2-1.5%
Triethanolamine 0.2-1.5%
0.2 to 1 percent of phenoxyethanol.
The beneficial effects of the invention are as follows: according to the invention, cannabidiol CBD is subjected to compatibility and synergism with 6-17 of centella extract, caulis Spatholobi extract, caulis Endadae Phaseoloidis extract, rhizoma Gastrodiae extract, rhizoma Zingiberis recens extract, radix Angelicae Pubescentis extract, semen Cuscutae extract, rhizoma Ligustici Chuanxiong extract, Atractylodis rhizoma extract, Carthami flos extract, cortex et radix Polygalae extract, radix aucklandiae extract, Myrrha extract, Olibanum extract, radix Angelicae sinensis extract, radix Saposhnikoviae extract, Notopterygii rhizoma extract, and the like, and vanillyl butyl ether is added to improve the use sensory effect, and a strong-permeability gel system is adopted to achieve the effects of rapidly relieving pain and ache and activating blood circulation to dissipate blood stasis.
Drawings
FIG. 1 is a table of the components of an analgesic and soothing industrial hemp leaf gel according to the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments.
Example 1
Referring to fig. 1, the industrial hemp leaf gel for easing pain is characterized in that the gel comprises the following specific components in parts by weight based on 100 parts by weight:
64.1 percent of water
30 percent of ethanol
Centella asiatica extract 0.2%
0.2 percent of suberect spatholobus stem extract
0.2% of Hylocereus undulatus extract
Rhizoma Gastrodiae extract 0.2%
Ginger extract 0.2%
Radix Angelicae Pubescentis extract 0.1%
Semen Cuscutae extract 0.1%
0.1 percent of ligusticum wallichii extract
0.1 percent of white atractylodes rhizome extract
0.1% of safflower extract
0.1% of polygala root extract
Radix aucklandiae extract 0.1%
0.1% of myrrh extract
Olibanum extract 0.1%
0.1% of angelica extract
0.1 percent of divaricate saposhnikovia root extract
0.1% of notopterygium root extract
Vanillyl butyl ether 2%
Hemp leaf extract 0.1%
Carbomer 0.7%
0.5 percent of triethanolamine
0.4 percent of phenoxyethanol.
We selected 10 people for experiments using the mask solution of the present invention, and the following table shows data and effects after 10 days, 20 days, 30 days, and 60 days:
Figure RE-DEST_PATH_IMAGE002
experimental data comparison Table 1
Note: (-general: + obvious: + good ++ and +++ very good.)
As shown by comparing the experimental data with the table 1, most users have obvious effect after using the facial mask liquid, and the effect is very obvious after using the facial mask liquid for 60 days.
CBD, one of the main chemical components in industrial hemp, has no mental activity, and has prominent performances in various aspects of anti-allergy, anti-inflammation, anti-oxidation, moisture retention, whitening, pain relief, sleep promotion and the like in daily necessities. In recent years, Cannabidiol (CBD) is leading to an unlimited value of the sunward industry due to its unique characteristics.
Cannabidiol CBD can produce analgesic effect. The pharmacological mechanisms of analgesia are mainly related to the CB1 receptor and the CB2 receptor. The CB1 receptor exerts analgesic effects by directly inhibiting the release of gamma aminobutyric acid, (GABA) and glutamate in the spinal cord from the grey matter surrounding the midbrain aqueduct and in the RVM. CB2 receptor inhibits allergic inflammation by attenuating nerve growth factor-induced mast cell degranulation and neutrophil accumulation, and thus mediates immunosuppression, and achieves anti-inflammatory and analgesic effects, which are stronger than those of aspirin, which is well known and widely used. The cannabidiol CBD is added into a smearing type analgesic product, is combined with the traditional Chinese medicine for promoting blood circulation and removing blood stasis through a penetration-promoting formula system, and is added with the vanillyl butyl ether to improve the sensory effect of use, so that the product achieves the effects of quickly relieving pain and activating blood circulation and removing blood stasis. The method has positive promotion effect on the improvement of application technology of cannabidiol raw materials in daily chemicals, and has important strategic significance on the improvement of the whole research and development level of domestic cosmetics.
The analgesic effect of cannabidiol CBD combines various traditional Chinese medicines with the effects of dispelling wind, dredging collaterals, promoting blood circulation, removing blood stasis, promoting wound healing, calming, dredging tendons and activating collaterals, adding vanillyl butyl ether enables the using part to have obvious warm feeling, and the hydrogel formula system is adopted to enable the product to quickly permeate and take effect when in use through the strong permeation effect of ethanol, so that the product has good instant effect on symptoms such as rheumatism strain, waist soreness, backache, traumatic injury and the like.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (1)

1. The industrial hemp leaf gel for easing pain is characterized by comprising the following specific components in parts by weight based on 100 parts by weight:
30 to 70 percent of water
10 to 60 percent of ethanol
Centella asiatica extract 0.01-2%
0.01-2% of caulis Spatholobi extract
0.01-2% of Hylocereus undatus extract
Rhizoma Gastrodiae extract 0.01-2%
Ginger extract 0.01-2%
Radix Angelicae Pubescentis extract 0.01-2%
Semen Cuscutae extract 0.01-2%
Rhizoma Ligustici Chuanxiong extract 0.01-2%
0.01-2% of white atractylodes rhizome extract
Carthami flos extract 0.01-2%
0.01-2% of polygala root extract
Radix aucklandiae extract 0.01-2%
0.01-2% of myrrh extract
Olibanum extract 0.01-2%
0.01-2% of angelica extract
0.01-2% of radix Saposhnikoviae extract
Notopterygii rhizoma extract 0.01-2%
0.1 to 3 percent of vanillyl butyl ether
Folium Cannabis extract 0.05-5%
Carbomer 0.2-1.5%
Triethanolamine 0.2-1.5%
0.2 to 1 percent of phenoxyethanol.
CN202010810989.8A 2020-08-13 2020-08-13 Industrial hemp leaf gel for easing pain Pending CN111956772A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010810989.8A CN111956772A (en) 2020-08-13 2020-08-13 Industrial hemp leaf gel for easing pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010810989.8A CN111956772A (en) 2020-08-13 2020-08-13 Industrial hemp leaf gel for easing pain

Publications (1)

Publication Number Publication Date
CN111956772A true CN111956772A (en) 2020-11-20

Family

ID=73365806

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010810989.8A Pending CN111956772A (en) 2020-08-13 2020-08-13 Industrial hemp leaf gel for easing pain

Country Status (1)

Country Link
CN (1) CN111956772A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113577203A (en) * 2021-09-02 2021-11-02 陈守海 Composition for treating tinea unguium due to qi of feet and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1839952A (en) * 2005-12-22 2006-10-04 清华大学深圳研究生院 Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis
CN101966298A (en) * 2010-09-29 2011-02-09 赵树栋 Traditional Chinese medicine for treating wind-cold numbness
CN106540230A (en) * 2016-11-25 2017-03-29 浙江塑香堂生物科技股份有限公司 It is a kind of for alleviating quintessence oils of disease such as cervical spondylosiss, lumbar spondylosiss and preparation method thereof
CN110448648A (en) * 2019-09-05 2019-11-15 黄菊容 A kind of Chinese medicine preparation and preparation method thereof for logical muscle of invigorating blood circulation
CN110840861A (en) * 2019-10-22 2020-02-28 福建龙生生物科技有限公司 Cervical vertebra plaster formula for clearing and activating channels and collaterals and preparation method of plaster of cervical vertebra plaster formula

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1839952A (en) * 2005-12-22 2006-10-04 清华大学深圳研究生院 Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis
CN101966298A (en) * 2010-09-29 2011-02-09 赵树栋 Traditional Chinese medicine for treating wind-cold numbness
CN106540230A (en) * 2016-11-25 2017-03-29 浙江塑香堂生物科技股份有限公司 It is a kind of for alleviating quintessence oils of disease such as cervical spondylosiss, lumbar spondylosiss and preparation method thereof
CN110448648A (en) * 2019-09-05 2019-11-15 黄菊容 A kind of Chinese medicine preparation and preparation method thereof for logical muscle of invigorating blood circulation
CN110840861A (en) * 2019-10-22 2020-02-28 福建龙生生物科技有限公司 Cervical vertebra plaster formula for clearing and activating channels and collaterals and preparation method of plaster of cervical vertebra plaster formula

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113577203A (en) * 2021-09-02 2021-11-02 陈守海 Composition for treating tinea unguium due to qi of feet and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101518507B (en) Tibetan incense cosmetic daily chemical product and preparation method thereof
CN1977916A (en) Chinese medicine composition for treating skin disease
CN102233085A (en) External application drug for treating skin diseases
CN101797293B (en) Chinese medicinal pillow core for treating cervical spondylosis and preparation method thereof
CN103932962A (en) Chinese herbal medicine acne-removal repair compound cosmetic and preparation method thereof
CN104984074A (en) Feature-beautifying skin-care product and production method and application thereof
CN107095828B (en) Daily chemical product composition with skin barrier repair function and preparation method and application thereof
CN111956772A (en) Industrial hemp leaf gel for easing pain
CN101244235B (en) Scraping oil, preparation method and application thereof
CN104887591A (en) Composition for controlling oil, removing acne and resurfacing scars
CN109045255A (en) A kind of drug and preparation method thereof that clearing damp is warded off the cold
CN110013462B (en) Artemisia argyi paste for whitening and protecting skin and preparation method thereof
CN100459971C (en) Anti-frozen skin-care cream and preparation method
CN105232637A (en) Aromatic pain-relieving ointment for massaging to relieve pain
CN100413527C (en) Iron bar spray of Tibetan medicine
CN103341044A (en) Itching-relieving compound preparation and preparation method thereof
CN104225123A (en) Tendon-relaxing and bone-strengthening plaster and preparation method thereof
CN102727418A (en) Cosmetic product with whitening, moisturizing and freckle removing effects
CN108567891B (en) Traditional Chinese medicine composition for removing acne and clearing acne marks and preparation method and application thereof
CN100408071C (en) Chinese medicine for preventing and treating baldness by snuff
CN105012483A (en) Traditional Chinese medicinal composition for treating head seborrheic dermatitis and preparation method thereof
CN1063413A (en) Pain relieving message emulsion
CN1069539C (en) Medicinal composition for curing acne and folliculitis and its preparation method
CN1100629A (en) Perfume relaxing tendons and relieving pain
CN109260263A (en) Alleviate muscle arthrosis pain and improves the composition for external application of tubercle, fascia

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201120

RJ01 Rejection of invention patent application after publication